The logos of Danish drugmaker Novo Nordisk, shaper of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy is seen extracurricular theri gathering arsenic the institution presents the yearly study astatine Novo Nordisk successful Bagsvaerd, Denmark, connected February 5, 2025.
Mads Claus Rasmussen | Afp | Getty Images
Several Novo Nordisk committee members volition measurement down from their positions aft clashing with the controlling shareholder connected the make-up of the firm.
The Danish pharma elephantine said Tuesday that committee directors and the Novo Nordisk Foundation — the firm's controlling shareholder — had failed to scope an statement connected the aboriginal creation of the board.
"The Board projected a renewal focusing connected summation of select, caller competencies portion besides maintaining continuity, whereas the Board of the Foundation wanted a much extended reconfiguration," said Helge Lund, seat of the committee of directors.
Shares fell 1% arsenic of 1:22 p.m. London time.
Chair Helge Lund, Vice Chair Henrik Poulsen and the autarkic committee members Laurence Debroux, Andreas Fibig, Sylvie Grégoire, Christina Law and Martin Mackay volition not basal for predetermination astatine the Extraordinary General Meeting, the institution said.
This is simply a breaking quality story. Please refresh for updates.
English (US) ·